Amedeo Smart

Free Medical Literature Service

 

Amedeo

Nuclear Medicine
  Free Subscription

15.04.2024

1 AJNR Am J Neuroradiol
1 Ann Nucl Med
1 BMC Neurol
1 Brain
1 Circulation
26 Clin Nucl Med
2 J Am Coll Cardiol
1 J Nucl Cardiol
5 J Nucl Med
1 Lancet
1 Nat Rev Neurol
1 Neurology
1 Nucl Med Commun
1 Nuklearmedizin
1 PLoS One


    AJNR Am J Neuroradiol

  1. KIM JT, Chang SJC, Haghdel A, Ramakrishna RR, et al
    DOTATATE PET/MR Imaging Differentiates Secondary-Progressive from de Novo World Health Organization Grade 3 Meningiomas.
    AJNR Am J Neuroradiol. 2024 Apr 11. doi: 10.3174/ajnr.A8219.
    >> Share


    Ann Nucl Med

  2. SUNG C, Oh JS, Park BS, Kim SS, et al
    Diagnostic performance of a deep-learning model using (18)F-FDG PET/CT for evaluating recurrence after radiation therapy in patients with lung cancer.
    Ann Nucl Med. 2024 Apr 8. doi: 10.1007/s12149-024-01925.
    >> Share


    BMC Neurol

  3. SVENSSON JE, Bolin M, Thor D, Williams PA, et al
    Evaluating the effect of rapamycin treatment in Alzheimer's disease and aging using in vivo imaging: the ERAP phase IIa clinical study protocol.
    BMC Neurol. 2024;24:111.
    >> Share


    Brain

  4. WANG YT, Therriault J, Servaes S, Tissot C, et al
    Sex-specific modulation of amyloid-beta on tau phosphorylation underlies faster tangle accumulation in females.
    Brain. 2024;147:1497-1510.
    >> Share


    Circulation

  5. DORBALA S
    Right Ventricular Bone-Avid Tracer Uptake: A Novel Risk Marker in Transthyretin Amyloid Cardiomyopathy.
    Circulation. 2024;149:1169-1171.
    >> Share


    Clin Nucl Med

  6. AK SIVRIKOZ I, Deveci H, Yildirim N
    A Rare False-Positive Whole-Body Scan in a Patient With Differentiated Thyroid Cancer: Unilateral Conjunctival Concretions.
    Clin Nucl Med. 2024;49:451-453.
    >> Share

  7. RUIKE Y, Suzuki S, Yokote K
    Increasing Catecholamine Secretion Through NPY in Pheochromocytomas With False-Negative 123 I-MIBG Scintigraphy.
    Clin Nucl Med. 2024;49:419-426.
    >> Share

  8. YANG H, Liu H, Li H, Zhang Y, et al
    177 Lu-FAP-2286 Therapy in a Metastatic Bone Malignant Solitary Fibrous Tumor.
    Clin Nucl Med. 2024;49:472-474.
    >> Share

  9. KARAMIAN F, Sadeghi R, Aghaee A, Askari E, et al
    Nonmalignant 68 Ga-FAPI-46 Uptake in 2 Cases of TENIS Syndrome : Comparison With 18 F-FDG.
    Clin Nucl Med. 2024;49:e213-e214.
    >> Share

  10. KAVANAUGH M, Shah HJ
    Widespread Reactive Lymphatic and Splenic FDG Avidity After mRNA COVID Vaccination.
    Clin Nucl Med. 2024;49:457-458.
    >> Share

  11. DE VRIES-HUIZING DMV, Cheung ZJ, Hendrikx JJMA, Donswijk ML, et al
    Extravasation After [ 177 Lu]Lu-HA-DOTATATE Therapy.
    Clin Nucl Med. 2024;49:454-456.
    >> Share

  12. AGGARWAL P, Sood A, Kumar R, Singh H, et al
    Unusual Sites of Visceral Spread in Prostate Cancer: A Prostate-Specific Membrane Antigen-Based Theranostic Imaging Series.
    Clin Nucl Med. 2024;49:e222-e226.
    >> Share

  13. BEYHAN E, Erol Fenercioglu O, Sahin R, Cermik TF, et al
    Dual 177 Lu-Prostate-Specific Membrane Antigen and 177 Lu-DOTATATE Therapy in Metastatic Castration-Resistant Prostate Cancer With Neuroendocrine Differentiation.
    Clin Nucl Med. 2024;49:447-448.
    >> Share

  14. SINGH A, Shah HJ, Dabiri BE, Landman W, et al
    Renal Collision Tumor: A Case of Small Cell Lung Cancer Metastasis to Renal Angiomyolipoma.
    Clin Nucl Med. 2024 Feb 23. doi: 10.1097/RLU.0000000000005136.
    >> Share

  15. LIANG Z, Li W
    Uptake of 99mTc-DTPA in Bone Metastases From Follicular Thyroid Carcinoma.
    Clin Nucl Med. 2024 Feb 7. doi: 10.1097/RLU.0000000000005100.
    >> Share

  16. DENG J, Sun Y, He R, Cai L, et al
    FDG Uptake Caused by Right Varicocele.
    Clin Nucl Med. 2024;49:449-450.
    >> Share

  17. SICILIA POZO MLN, Lopez-Bermejo Garcia F, Ruiz Disotuar N, Alarcon Molero L, et al
    Neuroendocrine Tumor Presented With Axillary Mass: A Case Report.
    Clin Nucl Med. 2024;49:e230-e232.
    >> Share

  18. WANG Q, Zhou Y, Chen X
    Elevated 68 Ga-FAPI Activity in Leiomyosarcoma.
    Clin Nucl Med. 2024;49:e197-e198.
    >> Share

  19. SMITH MV, Lang HJ, Donev K, Bendok BR, et al
    68Ga-DOTATATE and 18F-FDG PET Imaging of a Rare Chordoid Meningioma With Intracranial Recurrence and Extracranial Metastases.
    Clin Nucl Med. 2024 Apr 5. doi: 10.1097/RLU.0000000000005237.
    >> Share

  20. ZHANG W, Liu L, Yuan G, Deng M, et al
    Comparison of 18F-MFBG PET/CT and 18F-FDG PET/CT Images of Metastatic Neuroblastoma.
    Clin Nucl Med. 2024 Apr 5. doi: 10.1097/RLU.0000000000005226.
    >> Share

  21. CHEN X, Chen G, Li Q, Fu Z, et al
    18F-FDG PET/CT in Solitary Extramedullary Plasmacytoma of the Penis.
    Clin Nucl Med. 2024 Apr 5. doi: 10.1097/RLU.0000000000005234.
    >> Share

  22. DESAI C, Clark A, Surasi DS, Flynt L, et al
    Detection of Adenocarcinoma of the Colon on 18F-Fluciclovine PET/CT.
    Clin Nucl Med. 2024 Apr 5. doi: 10.1097/RLU.0000000000005218.
    >> Share

  23. WEI J, Chen X
    68Ga-FAPI-04 PET/CT Imaging of Mesenteric Aggressive Fibromatosis.
    Clin Nucl Med. 2024 Apr 5. doi: 10.1097/RLU.0000000000005219.
    >> Share

  24. DAWOD M, Rush E, Nagib PB, Aduwo J, et al
    The Utility of Prostate-Specific Membrane Antigen-11 PET in Detection and Management of Central Nervous System Neoplasms.
    Clin Nucl Med. 2024 Apr 5. doi: 10.1097/RLU.0000000000005157.
    >> Share

  25. AGGARWAL P, Ambalavanan N, Sood A, Gupta K, et al
    Prostate-Specific Membrane Antigen-Avid Neurofibroma Mimicking Cutaneous Metastasis in Metastatic Castration-Resistant Prostate Cancer on 18F-PSMA-1007 PET/CT.
    Clin Nucl Med. 2024 Apr 8. doi: 10.1097/RLU.0000000000005228.
    >> Share

  26. XU Y, Wang G, Wang Y, Wang W, et al
    Diagnostic Role of FDG PET/CT in Pediatric Patients With Chronic Recurrent Multifocal Osteomyelitis.
    Clin Nucl Med. 2024 Apr 5. doi: 10.1097/RLU.0000000000005216.
    >> Share

  27. WU H, Lu L, Dong A, Han Y, et al
    Juxtaglomerular Cell Tumor Mimicking Renal Cell Carcinoma on 99mTc-MIBI SPECT/CT.
    Clin Nucl Med. 2024 Apr 8. doi: 10.1097/RLU.0000000000005223.
    >> Share

  28. YAO X, Wang H, Kan Y, Wang W, et al
    Splenic Pseudoprogression After CAR-T Therapy Detected by 18F-FDG PET/CT in a Refractory Diffuse Large B-Cell Lymphoma Patient.
    Clin Nucl Med. 2024 Apr 8. doi: 10.1097/RLU.0000000000005221.
    >> Share

  29. GUO L, Shen G
    Gastric Fundus Splenosis Mimicking Malignancy on FDG PET/CT.
    Clin Nucl Med. 2024 Apr 10. doi: 10.1097/RLU.0000000000005171.
    >> Share

  30. WANG P, Li T, Zhuang H, Li F, et al
    18F-MFBG PET/CT and MRI in Identifying Brain Metastases in a Posttreatment Neuroblastoma Patient.
    Clin Nucl Med. 2024 Apr 8. doi: 10.1097/RLU.0000000000005224.
    >> Share

  31. BASAVALINGU D, Sadic M, Cheeney S, Parisi MT, et al
    A Rare Case of Abnormal Diffuse Brain Uptake on an 123I MIBG Scan in a Patient With High-Risk Neuroblastoma.
    Clin Nucl Med. 2024;49:438-441.
    >> Share


    J Am Coll Cardiol

  32. DAYER MJ, Quintero-Martinez JA, Thornhill MH, Chambers JB, et al
    Recent Insights Into Native Valve Infective Endocarditis: JACC Focus Seminar 4/4.
    J Am Coll Cardiol. 2024;83:1431-1443.
    >> Share

  33. CUERVO G, Quintana E, Regueiro A, Perissinotti A, et al
    The Clinical Challenge of Prosthetic Valve Endocarditis: JACC Focus Seminar 3/4.
    J Am Coll Cardiol. 2024;83:1418-1430.
    >> Share


    J Nucl Cardiol

  34. SPERRY BW, Vuppala S
    Sequential FDG PET Imaging in Cardiac Sarcoidosis.
    J Nucl Cardiol. 2024 Apr 5:101860. doi: 10.1016/j.nuclcard.2024.101860.
    >> Share


    J Nucl Med

  35. QI C, Guo R, Chen Y, Li C, et al
    (68)Ga-NC-BCH Whole-Body PET Imaging Rapidly Targets Claudin18.2 in Lesions in Gastrointestinal Cancer Patients.
    J Nucl Med. 2024 Apr 11:jnumed.123.267110. doi: 10.2967/jnumed.123.267110.
    >> Share

  36. ROHRICH M, Daum J, Gutjahr E, Spektor AM, et al
    Diagnostic Potential of Supplemental Static and Dynamic (68)Ga-FAPI-46 PET for Primary (18)F-FDG-Negative Pulmonary Lesions.
    J Nucl Med. 2024 Apr 11:jnumed.123.267103. doi: 10.2967/jnumed.123.267103.
    >> Share

  37. O'DONNELL JL, Soda AK, Jiang H, Norris SA, et al
    PET Quantification of [(18)F]VAT in Human Brain and Its Test-Retest Reproducibility and Age Dependence.
    J Nucl Med. 2024 Apr 11:jnumed.123.266860. doi: 10.2967/jnumed.123.266860.
    >> Share

  38. VISCUSE P, Devitt M, Dreicer R
    Clinical Management of Advanced Prostate Cancer: Where Does Radiopharmaceutical Therapy Fit in the Treatment Algorithm?
    J Nucl Med. 2024 Apr 11:jnumed.123.267006. doi: 10.2967/jnumed.123.267006.
    >> Share

  39. WU Q, Gu F, O'Suilleabhain LD, Sari H, et al
    Mapping (18)F-FDG Kinetics Together with Patient-Specific Bootstrap Assessment of Uncertainties: An Illustration with Data from a PET/CT Scanner with a Long Axial Field of View.
    J Nucl Med. 2024 Apr 11:jnumed.123.266686. doi: 10.2967/jnumed.123.266686.
    >> Share


    Lancet

  40. PEREZ-GARCIA JM, Cortes J, Ruiz-Borrego M, Colleoni M, et al
    3-year invasive disease-free survival with chemotherapy de-escalation using an (18)F-FDG-PET-based, pathological complete response-adapted strategy in HER2-positive early breast cancer (PHERGain): a randomised, open-label, phase 2 trial.
    Lancet. 2024 Apr 3:S0140-6736(24)00054-0. doi: 10.1016/S0140-6736(24)00054.
    >> Share


    Nat Rev Neurol

  41. THERRIAULT J, Schindler SE, Salvado G, Pascoal TA, et al
    Biomarker-based staging of Alzheimer disease: rationale and clinical applications.
    Nat Rev Neurol. 2024 Mar 1. doi: 10.1038/s41582-024-00942.
    >> Share


    Neurology

  42. RUS T, Cuderman A, Georgiev D
    Parkinsonism Associated With Traumatic Hemorrhage in Substantia Nigra: Role of Presynaptic Dopaminergic Imaging.
    Neurology. 2024;102:e209384.
    >> Share


    Nucl Med Commun

  43. KUMAR P, Arora P, Kumar R, Singh H, et al
    Evaluation of skull bone viability and effect of early surgical intervention in electrical contact burns using 18F-Sodium Fluoride PET-CT imaging.
    Nucl Med Commun. 2024 Apr 9. doi: 10.1097/MNM.0000000000001842.
    >> Share


    Nuklearmedizin

  44. WIELENBERG CF, Fostitsch JC, Volz C, Marks R, et al
    FDG-PET/CT is a powerful tool to predict and evaluate response to chimeric antigen receptor (CAR) T-cell therapy in Non-Hodgkin-Lymphoma (NHL).
    Nuklearmedizin. 2024 Apr 9. doi: 10.1055/a-2283-8417.
    >> Share


    PLoS One

  45. ISSA ASM, Scheins J, Tellmann L, Brambilla CR, et al
    Impact of improved dead time correction on the quantification accuracy of a dedicated BrainPET scanner.
    PLoS One. 2024;19:e0296357.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016